🇺🇸 FDA
Patent

US 7452723

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

granted A61KA61K35/765A61K38/13

Quick answer

US patent 7452723 (Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders) held by ONCOLYTICS BIOTECH INC. expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ONCOLYTICS BIOTECH INC.
Grant date
Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K35/765, A61K38/13, A61P, A61P1/00